Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Andrea Steck

Concepts (305)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Diabetes Mellitus, Type 1
103
2024
3245
8.860
Why?
Autoantibodies
64
2024
1354
7.070
Why?
Islets of Langerhans
37
2023
729
4.350
Why?
Autoimmunity
33
2022
818
3.000
Why?
C-Peptide
12
2022
138
2.680
Why?
Insulin Antibodies
11
2022
102
2.540
Why?
Genetic Predisposition to Disease
32
2022
2108
2.090
Why?
Polymorphism, Single Nucleotide
23
2021
1901
1.900
Why?
Blood Glucose
13
2023
1821
1.800
Why?
Glutamate Decarboxylase
17
2022
160
1.790
Why?
Insulin
21
2023
2082
1.650
Why?
Disease Progression
33
2022
2389
1.600
Why?
Protein Tyrosine Phosphatase, Non-Receptor Type 22
7
2019
46
1.460
Why?
HLA-DR Antigens
8
2016
220
1.370
Why?
Child, Preschool
54
2023
9093
1.360
Why?
Child
74
2023
18407
1.350
Why?
Genotype
22
2020
1780
1.170
Why?
Adolescent
54
2023
17864
1.050
Why?
HLA-DQ Antigens
8
2019
177
1.030
Why?
Infant
34
2023
7946
0.980
Why?
HLA-DR3 Antigen
8
2022
79
0.970
Why?
Receptor-Like Protein Tyrosine Phosphatases, Class 8
5
2017
58
0.940
Why?
Diabetes Mellitus, Type 2
10
2022
2098
0.920
Why?
Adaptor Proteins, Signal Transducing
4
2017
370
0.910
Why?
Insulin-Secreting Cells
11
2021
318
0.900
Why?
Blood Glucose Self-Monitoring
6
2023
497
0.890
Why?
Male
74
2023
55731
0.840
Why?
Humans
113
2024
115042
0.820
Why?
Female
74
2023
59613
0.800
Why?
Zinc Transporter 8
7
2021
86
0.800
Why?
Haplotypes
8
2022
455
0.780
Why?
Mass Screening
10
2022
1012
0.760
Why?
Hyperglycemia
2
2015
293
0.750
Why?
Age of Onset
12
2021
449
0.740
Why?
HLA-D Antigens
2
2019
34
0.740
Why?
Prediabetic State
4
2023
224
0.720
Why?
Young Adult
29
2022
10498
0.710
Why?
Prospective Studies
20
2024
6232
0.670
Why?
HLA Antigens
5
2022
224
0.660
Why?
Genetic Testing
6
2019
380
0.650
Why?
Glucose Tolerance Test
8
2023
344
0.650
Why?
C-Reactive Protein
2
2018
363
0.640
Why?
Risk Factors
28
2024
8642
0.630
Why?
Hypoglycemic Agents
5
2020
1006
0.620
Why?
Family
4
2018
591
0.600
Why?
Diagnostic Techniques, Endocrine
1
2017
14
0.590
Why?
Celiac Disease
4
2022
264
0.560
Why?
Sensitivity and Specificity
9
2022
1715
0.540
Why?
Case-Control Studies
12
2021
3015
0.510
Why?
HLA-DR4 Antigen
5
2022
76
0.470
Why?
Models, Genetic
1
2017
566
0.470
Why?
Proinsulin
2
2020
49
0.470
Why?
Polymorphism, Genetic
5
2019
617
0.430
Why?
Follow-Up Studies
10
2021
4420
0.430
Why?
Quality Improvement
2
2017
953
0.420
Why?
Luminescence
4
2016
34
0.420
Why?
Transcription Factor 7-Like 2 Protein
5
2021
24
0.420
Why?
HLA-DQ beta-Chains
4
2019
59
0.420
Why?
Luminescent Measurements
4
2021
74
0.410
Why?
Cation Transport Proteins
4
2017
123
0.400
Why?
Adult
26
2022
30656
0.370
Why?
DNA Methylation
4
2020
496
0.350
Why?
Risk
6
2019
815
0.330
Why?
Twins, Monozygotic
4
2018
210
0.330
Why?
Antigens, CD
2
2009
441
0.320
Why?
HLA-DQ alpha-Chains
3
2019
14
0.320
Why?
Cohort Studies
11
2021
4904
0.320
Why?
Family Health
4
2017
194
0.310
Why?
HLA-DRB1 Chains
3
2019
98
0.310
Why?
Predictive Value of Tests
6
2019
1812
0.300
Why?
Transglutaminases
2
2021
142
0.300
Why?
Major Histocompatibility Complex
4
2017
219
0.290
Why?
Longitudinal Studies
6
2020
2389
0.290
Why?
Pancreas
3
2024
280
0.290
Why?
Risk Assessment
5
2020
2976
0.280
Why?
CTLA-4 Antigen
3
2017
78
0.280
Why?
Alleles
4
2021
792
0.280
Why?
Age Factors
6
2022
2894
0.270
Why?
Autoimmune Diseases
3
2017
394
0.270
Why?
Protein Tyrosine Phosphatases
1
2006
147
0.260
Why?
Autoantigens
2
2021
397
0.250
Why?
Prognosis
6
2021
3334
0.250
Why?
Diabetes Complications
2
2018
212
0.250
Why?
Biomarkers
5
2021
3419
0.220
Why?
Hydroxychloroquine
1
2023
55
0.220
Why?
Gene Frequency
6
2020
483
0.220
Why?
Proportional Hazards Models
4
2021
1080
0.220
Why?
Infant, Newborn
7
2022
5040
0.210
Why?
Diabetic Ketoacidosis
2
2022
159
0.210
Why?
Glucokinase
2
2013
13
0.210
Why?
Radioimmunoassay
3
2017
163
0.200
Why?
Chromosome Mapping
2
2021
490
0.190
Why?
Early Diagnosis
3
2020
218
0.190
Why?
Seroconversion
1
2021
46
0.180
Why?
Area Under Curve
2
2020
275
0.180
Why?
Benchmarking
1
2022
161
0.180
Why?
Colorado
5
2023
4089
0.180
Why?
Twins, Dizygotic
2
2018
182
0.180
Why?
GTP-Binding Proteins
1
2021
141
0.180
Why?
Precision Medicine
1
2023
340
0.170
Why?
Iodide Peroxidase
2
2020
27
0.170
Why?
Phospholipids
1
2021
199
0.170
Why?
Incidence
4
2022
2318
0.160
Why?
Receptors, Antigen, T-Cell
2
2022
618
0.160
Why?
Insulin Resistance
3
2021
1077
0.160
Why?
Down-Regulation
1
2021
599
0.160
Why?
Genome-Wide Association Study
3
2019
1203
0.160
Why?
Diabetes Mellitus
2
2023
906
0.150
Why?
Kaplan-Meier Estimate
2
2017
814
0.150
Why?
ROC Curve
1
2019
447
0.150
Why?
Middle Aged
10
2022
26827
0.150
Why?
Multivariate Analysis
2
2016
1435
0.150
Why?
Fasting
2
2018
242
0.150
Why?
Receptors, CCR7
1
2017
24
0.150
Why?
Genetic Heterogeneity
1
2017
49
0.150
Why?
Discriminant Analysis
1
2017
38
0.150
Why?
Interferon-gamma
1
2021
723
0.150
Why?
Blood Specimen Collection
1
2017
32
0.140
Why?
Transcription Factors
2
2017
1531
0.140
Why?
Influenza, Human
1
2022
546
0.140
Why?
Health Care Costs
1
2020
381
0.140
Why?
Disease Management
1
2020
563
0.140
Why?
Genomics
1
2021
641
0.140
Why?
Genetic Variation
1
2021
876
0.130
Why?
Antibody Affinity
1
2016
52
0.130
Why?
Hypoglycemia
2
2020
385
0.130
Why?
Disease-Free Survival
1
2017
617
0.130
Why?
Peptides
1
2021
849
0.130
Why?
Tumor Necrosis Factor-alpha
1
2020
1138
0.130
Why?
Iron-Binding Proteins
1
2015
38
0.120
Why?
RNA, Long Noncoding
1
2017
155
0.120
Why?
Dried Blood Spot Testing
1
2015
72
0.120
Why?
Trans-Activators
1
2017
368
0.120
Why?
Intracellular Signaling Peptides and Proteins
1
2017
386
0.120
Why?
Repressor Proteins
1
2017
368
0.120
Why?
Antibodies, Monoclonal
1
2020
1268
0.120
Why?
Self Care
1
2017
351
0.120
Why?
Magnetic Resonance Imaging
2
2024
3118
0.110
Why?
Population Surveillance
1
2017
392
0.110
Why?
Glucose
3
2023
900
0.110
Why?
Hepatocyte Nuclear Factor 4
1
2013
13
0.110
Why?
Hepatocyte Nuclear Factor 1-alpha
1
2013
16
0.110
Why?
CD8-Positive T-Lymphocytes
1
2018
691
0.110
Why?
Genetic Linkage
2
2011
297
0.110
Why?
Protein Tyrosine Phosphatase, Non-Receptor Type 2
1
2012
11
0.100
Why?
Chromosomes, Human, Pair 2
2
2009
27
0.100
Why?
Receptors, Calcitriol
1
2012
53
0.100
Why?
United Kingdom
3
2018
227
0.100
Why?
Polymerase Chain Reaction
1
2014
999
0.100
Why?
Proteins
1
2017
915
0.100
Why?
Promoter Regions, Genetic
1
2016
1133
0.100
Why?
Genetic Association Studies
3
2020
344
0.090
Why?
Penetrance
1
2011
27
0.090
Why?
Siblings
2
2018
224
0.090
Why?
Dose-Response Relationship, Drug
1
2015
1857
0.090
Why?
Inflammation
2
2020
2485
0.090
Why?
DNA-Binding Proteins
1
2017
1318
0.090
Why?
Seroepidemiologic Studies
2
2023
138
0.090
Why?
Gene Expression
2
2021
1423
0.090
Why?
Vitamin D
1
2013
340
0.090
Why?
Glycopeptides
1
2010
43
0.090
Why?
Obesity
2
2019
2524
0.090
Why?
Genetic Markers
1
2011
323
0.090
Why?
Histocompatibility Antigens Class I
1
2011
174
0.080
Why?
Histocompatibility Antigens Class II
1
2011
353
0.080
Why?
Nuclear Family
1
2009
49
0.080
Why?
TCF Transcription Factors
1
2008
20
0.080
Why?
Oligonucleotide Array Sequence Analysis
1
2011
744
0.080
Why?
Asymptomatic Diseases
2
2021
75
0.080
Why?
Phenotype
2
2017
2815
0.080
Why?
DEAD-box RNA Helicases
1
2008
56
0.080
Why?
Mutation
2
2015
3350
0.070
Why?
Hospitalization
1
2016
1754
0.070
Why?
Protein Tyrosine Phosphatase, Non-Receptor Type 1
1
2006
44
0.070
Why?
Gene-Environment Interaction
2
2020
185
0.070
Why?
Biosensing Techniques
1
2007
99
0.070
Why?
CpG Islands
2
2016
118
0.070
Why?
Leukocytes, Mononuclear
1
2008
496
0.070
Why?
Receptors, Interleukin-4
1
2005
15
0.060
Why?
Cell Death
2
2019
324
0.060
Why?
Animals
4
2022
31867
0.060
Why?
Antigens, Differentiation
1
2005
79
0.060
Why?
Sex Characteristics
1
2010
635
0.060
Why?
CD4-Positive T-Lymphocytes
2
2021
965
0.060
Why?
Environment
2
2018
335
0.060
Why?
Interleukin-13
1
2005
123
0.060
Why?
Drug Delivery Systems
1
2007
296
0.060
Why?
Fathers
1
2005
45
0.060
Why?
Interleukin-4
1
2005
209
0.060
Why?
Europe
2
2015
336
0.060
Why?
Feasibility Studies
2
2017
746
0.050
Why?
Parents
2
2023
1190
0.050
Why?
Practice Guidelines as Topic
2
2023
1398
0.050
Why?
Prevalence
2
2023
2255
0.050
Why?
Time Factors
3
2018
6141
0.050
Why?
Stroke
1
2010
1015
0.050
Why?
Electrochemistry
1
2021
78
0.050
Why?
Reproducibility of Results
2
2021
2799
0.050
Why?
China
1
2021
163
0.050
Why?
Perception
1
2023
310
0.050
Why?
Consensus
1
2023
534
0.050
Why?
Diagnostic Techniques, Radioisotope
1
2021
8
0.050
Why?
Immunoglobulin D
1
2021
27
0.050
Why?
Diffusion Magnetic Resonance Imaging
1
2021
85
0.050
Why?
Sequence Analysis, DNA
2
2016
728
0.050
Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2022
309
0.050
Why?
Serologic Tests
1
2021
49
0.050
Why?
Latent Autoimmune Diabetes in Adults
1
2020
2
0.050
Why?
Phantoms, Imaging
1
2021
137
0.050
Why?
Protein Interaction Mapping
1
2021
102
0.050
Why?
Healthy Volunteers
1
2021
197
0.050
Why?
Electrochemical Techniques
1
2021
45
0.040
Why?
Aged
3
2021
19119
0.040
Why?
Drug Discovery
1
2021
124
0.040
Why?
Whole Genome Sequencing
1
2020
96
0.040
Why?
Glutens
1
2020
56
0.040
Why?
Peroxidase
1
2020
157
0.040
Why?
Mannose
1
2019
21
0.040
Why?
Quality-Adjusted Life Years
1
2020
101
0.040
Why?
Linkage Disequilibrium
2
2011
245
0.040
Why?
Immunoglobulin A
1
2021
171
0.040
Why?
Adenosine Diphosphate
1
2019
81
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2022
441
0.040
Why?
Immunoglobulin M
1
2021
251
0.040
Why?
Evidence-Based Medicine
1
2023
676
0.040
Why?
Antibodies, Viral
1
2023
522
0.040
Why?
Costs and Cost Analysis
1
2020
196
0.040
Why?
Immunoglobulin E
1
2021
323
0.040
Why?
Butyrates
1
2019
53
0.040
Why?
Mothers
1
2005
652
0.040
Why?
Ascorbic Acid
1
2019
110
0.040
Why?
Infant, Newborn, Diseases
1
2020
104
0.040
Why?
Methylation
1
2019
208
0.040
Why?
Fibrinogen
1
2019
155
0.040
Why?
Molecular Targeted Therapy
1
2021
347
0.040
Why?
Emotional Adjustment
1
2018
17
0.040
Why?
Antibody Specificity
1
2018
176
0.040
Why?
Interleukins
1
2020
236
0.040
Why?
Sweden
1
2018
65
0.040
Why?
Pennsylvania
1
2018
94
0.040
Why?
Germany
1
2018
85
0.040
Why?
Quantitative Trait Loci
1
2020
309
0.040
Why?
Drug Therapy, Combination
1
2020
955
0.040
Why?
Collagen
1
2020
416
0.040
Why?
Disease Susceptibility
1
2019
316
0.040
Why?
Anxiety
1
2023
845
0.040
Why?
Cost-Benefit Analysis
1
2020
544
0.040
Why?
Diseases in Twins
1
2018
175
0.040
Why?
Image Processing, Computer-Assisted
1
2021
698
0.040
Why?
Neoplasm Proteins
1
2020
385
0.030
Why?
Immunity, Innate
1
2022
723
0.030
Why?
Twins
1
2018
240
0.030
Why?
Capillaries
1
2017
91
0.030
Why?
Immunoglobulin G
1
2021
776
0.030
Why?
Molecular Sequence Annotation
1
2016
81
0.030
Why?
Double-Blind Method
1
2020
1664
0.030
Why?
Metabolomics
1
2021
527
0.030
Why?
Tertiary Care Centers
1
2016
126
0.030
Why?
Organ Specificity
1
2016
270
0.030
Why?
Fetal Blood
1
2016
270
0.030
Why?
Thyroid Gland
1
2015
83
0.030
Why?
North America
1
2015
259
0.030
Why?
Overweight
1
2018
474
0.030
Why?
Health Services Accessibility
1
2020
765
0.030
Why?
Patient Preference
1
2015
169
0.030
Why?
T-Lymphocytes
1
2021
1747
0.030
Why?
Research Design
1
2019
930
0.030
Why?
Hospitals, Pediatric
1
2016
477
0.030
Why?
Models, Biological
1
2019
1636
0.030
Why?
Genome
1
2014
271
0.030
Why?
DNA Mutational Analysis
1
2013
372
0.030
Why?
Ubiquitins
1
2011
31
0.020
Why?
Epigenesis, Genetic
1
2016
524
0.020
Why?
Patient Acceptance of Health Care
1
2017
679
0.020
Why?
DNA Replication
1
2011
202
0.020
Why?
Genetic Loci
1
2011
264
0.020
Why?
Treatment Outcome
2
2016
9122
0.020
Why?
Histocompatibility Testing
1
2010
116
0.020
Why?
Body Composition
1
2013
586
0.020
Why?
Telomere
1
2011
202
0.020
Why?
Cytokines
1
2017
1843
0.020
Why?
HLA-A Antigens
1
2009
50
0.020
Why?
HLA-B Antigens
1
2009
56
0.020
Why?
Hyperinsulinism
1
2010
103
0.020
Why?
Chromosomes, Human, Pair 5
1
2008
24
0.020
Why?
United States
2
2015
12226
0.020
Why?
Chromosomes, Human, Pair 3
1
2008
49
0.020
Why?
Interferon-Induced Helicase, IFIH1
1
2008
14
0.020
Why?
Severity of Illness Index
1
2016
2551
0.020
Why?
Homozygote
1
2009
188
0.020
Why?
Conserved Sequence
1
2009
218
0.020
Why?
Heterozygote
1
2009
251
0.020
Why?
Pedigree
1
2009
467
0.020
Why?
Base Sequence
1
2011
2119
0.020
Why?
DNA
1
2014
1352
0.020
Why?
Tissue Donors
1
2010
326
0.020
Why?
Genome, Human
1
2009
351
0.020
Why?
Molecular Sequence Data
1
2011
2796
0.020
Why?
Logistic Models
1
2011
1839
0.020
Why?
Mice
1
2022
14927
0.020
Why?
Body Mass Index
1
2013
1967
0.020
Why?
Registries
1
2013
1763
0.020
Why?
Gene Expression Profiling
1
2011
1523
0.020
Why?
Retrospective Studies
1
2016
12547
0.010
Why?
Aged, 80 and over
1
2010
6357
0.010
Why?
Steck's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)